- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Di | SciBase announces final outcome of directed issue and rights issue | 264 | PR Newswire | STOCKHOLM, Jan. 14, 2025 /PRNewswire/ -- SciBase Holding AB ("SciBase" or the "Company") today announces the final outcome of the capital raise, consisting of a rights issue of units of approximately... ► Artikel lesen | |
| SCIBASE Aktie jetzt für 0€ handeln | |||||
| 13.01. | SciBase announces outcome of directed issue and preliminary outcome of rights issue | 245 | PR Newswire | STOCKHOLM, Jan. 13, 2025 /PRNewswire/ -- SciBase Holding AB ("SciBase" or the "Company") today announces the preliminary outcome of the capital raise, consisting of a rights issue of units... ► Artikel lesen | |
| 03.01. | SciBase: The Mayo Clinic, the leading US hospital, will test Nevisense in Pilot | 300 | PR Newswire | STOCKHOLM, Jan. 3, 2025 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO: SCIB), a leading developer of augmented intelligence-based solutions for skin disorders, announced today that... ► Artikel lesen | |
| 27.12.24 | Today the subscription period in SciBase rights issue begins | 437 | PR Newswire | STOCKHOLM, Dec. 27, 2024 /PRNewswire/ -- Today, on December 27, 2024, is the first day of the subscription period in SciBase Holding AB's ("SciBase" or the "Company") rights issue of units... ► Artikel lesen | |
| 20.12.24 | SciBase letter from the CEO | 330 | PR Newswire | STOCKHOLM, Dec. 20, 2024 /PRNewswire/ -- In 2024, SciBase has advanced its positions significantly and laid the foundation for continued growth, with a new organization in the US, success... ► Artikel lesen | |
| 20.12.24 | SciBase publishes prospectus | 334 | PR Newswire | STOCKHOLM, Dec. 20, 2024 /PRNewswire/ -- SciBase Holding AB ("SciBase" or the "Company") announced on November 12, 2024 that the Board of Directors has resolved, subject to the subsequent... ► Artikel lesen | |
| 18.12.24 | XFRA CAPITAL ADJUSTMENT INFORMATION - 18.12.2024 | 275 | Xetra Newsboard | Das Instrument 087 GB00BD7XPJ64 NEWRIVER REIT LS-,01 EQUITY wird cum Kapitalmassnahme gehandelt am 18.12.2024 und ex Kapitalmassnahme am 19.12.2024 The instrument 087 GB00BD7XPJ64 NEWRIVER REIT LS-... ► Artikel lesen | |
| 13.12.24 | Bulletin from the extraordinary general meeting in SciBase Holding AB (publ) | 316 | PR Newswire | STOCKHOLM, Dec. 13, 2024 /PRNewswire/ -- Today, an extraordinary general meeting has been held in SciBase Holding AB (publ) ("SciBase" or the "Company"). The general meeting resolved in accordance... ► Artikel lesen | |
| 13.11.24 | SciBase Announces Positive Findings in Case Study Monitoring Treatment Outcomes in Atopic Dermatitis Patient | 387 | PR Newswire | STOCKHOLM, Nov. 13, 2024 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO: SCIB), a leading developer of artificial intelligence (AI)-based solutions for skin is excited to announce the... ► Artikel lesen | |
| 12.11.24 | Notice to extraordinary general meeting in Scibase Holding AB (publ) | 260 | PR Newswire | STOCKHOLM, Nov. 12, 2024 /PRNewswire/ -- Shareholders of SciBase Holding AB (publ), reg. no. 556773-4768 (the "Company"), are hereby summoned to an extraordinary general meeting to be held... ► Artikel lesen | |
| 12.11.24 | SciBase announces collaboration for prediction of atopic dermatitis in infants | 324 | PR Newswire | STOCKHOLM, Nov. 12, 2024 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO: SCIB), a leading developer of augmented intelligence-based solutions for skin disorders, announced today its... ► Artikel lesen | |
| 12.11.24 | SciBase decides on a directed issue of approximately SEK 22.5 million and a rights issue of up to approximately SEK 59.3 million | 445 | PR Newswire | STOCKHOLM, Nov. 12, 2024 /PRNewswire/ -- The Board of Directors of SciBase Holding AB (publ) ("SciBase" or the "Company") has today decided to carry out a capital raise totaling approximately... ► Artikel lesen | |
| 12.11.24 | SciBase: Interim report January 1 - September 30, 2024 | 262 | PR Newswire | STOCKHOLM, Nov. 12, 2024 /PRNewswire/ -- January 1 - September 30, 2024
The third quarter in figures
Net sales were TSEK 8,408 (7,248), +16%.The loss after tax was TSEK 17,753... ► Artikel lesen | |
| 30.10.24 | SciBase initiates sales collaboration in Italy | 201 | PR Newswire |
STOCKHOLM, Oct. 30, 2024 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO: SCIB), a leading developer of augmented intelligence-based solutions for skin disorders announces today the collaboration... ► Artikel lesen | |
| 21.10.24 | SciBase continues US expansion and will attend Fall Clinical conference | 319 | PR Newswire | STOCKHOLM, Oct. 21, 2024 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO: SCIB), a leading developer of augmented intelligence-based solutions for skin disorders will attend a leading... ► Artikel lesen | |
| 14.10.24 | Nomination Committee appointed for SciBase Holding's Annual General Meeting in 2025 | 348 | PR Newswire | STOCKHOLM, Oct. 14, 2024 /PRNewswire/ -- The following people have been appointed as members of SciBase Holding's nominating committee for the Annual General Meeting in 2025:
Anders... ► Artikel lesen | |
| 27.09.24 | SciBase announces sale of Nevisense to NIH (US) | 250 | PR Newswire | STOCKHOLM, Sept. 27, 2024 /PRNewswire/ -- SciBase Holding AB ("SciBase") [STO: SCIB], pioneering prevention and prediction in dermatology disorders is pleased to announce the completion of... ► Artikel lesen | |
| 26.09.24 | SciBase expands to new market in Pennsylvania and receives first order from large dermatology practice | 333 | PR Newswire | STOCKHOLM, Sept. 26, 2024 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO: SCIB), pioneering prevention and prediction in dermatology announces today a partnership with Seraly Dermatology... ► Artikel lesen | |
| 02.09.24 | SciBase: New US Consensus Report supports Nevisense | 343 | PR Newswire | Consensus reached by top US clinicians assessing technologies for melanoma detection and managementThe report concludes that the Nevisense AI-driven technology can significantly enhance early... ► Artikel lesen | |
| 21.08.24 | SciBase changes Certified Adviser to Carnegie Investment Bank AB (publ) | 341 | PR Newswire | STOCKHOLM, Aug. 21, 2024 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO: SCIB), SciBase, a leading developer of augmented intelligence-based solutions for skin, hereby announces change... ► Artikel lesen |
Seite:
1 2 3 Weiter >>
55 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ROKU | 72,70 | -1,58 % | Roku (NASDAQ:ROKU) Stock Price Up 1% - Should You Buy? | ||
| SERNOVA | 0,142 | -0,91 % | Sernova Corp: Sernova shareholders elect six directors at ASM | ||
| BOSTON SCIENTIFIC | 96,50 | 0,00 % | Kurznachrichten zu Boston Scientific, Encavis und zu Veränderungen im SDAX | Mit unseren Kurznachrichten bieten wir kompakte Updates zu einer Handvoll ausgewählter Aktien für den perfekten Überblick - prägnant, informativ und auf den Punkt. Die Aktie von Boston Scientific hat... ► Artikel lesen | |
| PAUL HARTMANN | 226,00 | +1,80 % | Paul Hartmann: Jedes Quartal die Prognose erhöht | Mit Aktien von Medizintechnikunternehmen war auch 2024 kaum etwas zu verdienen. Bekannte Titel wie Carl Zeiss Meditec, Stratec und Sartorius sorgten in den vergangenen zwölf Monaten sogar für herbe... ► Artikel lesen | |
| ADDLIFE | 11,960 | -1,73 % | AddLife AB: Interim Report 1 January - 30 September 2024 | Organic growth and stable margin while profitability improvement initiatives are progressing
"Continued organic growth and stable margin in the third quarter - a quarter that is normally somewhat weaker... ► Artikel lesen | |
| EMBECTA | 18,200 | 0,00 % | Analysts say Embecta is 'heading in the right direction' following patch pump discontinuation | ||
| SYSMEX | 17,700 | 0,00 % | Dividendenbekanntmachungen (27.09.2024) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ABRDN EUROPEAN LOGISTICS INCOME PLC GB00BD9PXH49 0,0077 GBP EUR ACADIAN TIMBER CORP CA0042721005 0,29 CAD 0,1926 EUR ACOM CO LTD JP3108600002 7... ► Artikel lesen | |
| R1 RCM | 13,400 | 0,00 % | R1 RCM Inc. (RCM): Driving Strong Revenue Growth with AI-Driven Solutions and Strategic Partnerships in Healthcare | ||
| ENOVIS | 45,000 | +1,81 % | Enovis Corporation: Enovis Announces Leadership Change to International Surgical Business | Wilmington, DE, Jan. 17, 2025 (GLOBE NEWSWIRE) -- Enovis, a global medical technology innovator headquartered in the United States, announced recently that Davide Visentin will succeed Dr. Benjamin... ► Artikel lesen | |
| PULMONX | 6,550 | +7,38 % | Pulmonx Corp - 10-Q, Quarterly Report | ||
| KANGJI MEDICAL | 0,720 | +0,70 % | KANGJI MEDICAL (09997): NEXT DAY DISCLOSURE RETURN | ||
| SI-BONE | 13,200 | 0,00 % | SI-BONE, Inc.: SI-BONE Announces Preliminary Revenue for the Fourth Quarter and Full Year 2024 | Fourth Quarter 2024 worldwide revenue of ~$48.8 to $49.0 million representing growth of ~26%Achieved adjusted EBITDA profitability in the fourth quarter SANTA CLARA, Calif., Jan. 13, 2025 (GLOBE NEWSWIRE)... ► Artikel lesen | |
| PEIJIA MEDICAL | 0,458 | +6,02 % | Peijia Medical Announces 2024 Interim Results | HONG KONG, Aug. 26, 2024 /PRNewswire/ -- Peijia Medical (HKG:9996), a leading Chinese domestic player in the high-growth transcatheter valve therapeutics and neurovascular interventions markets... ► Artikel lesen | |
| KOOTH | 2,080 | +0,97 % | Kooth (LON:KOO) Stock Price Up 10.6% - Here's Why | ||
| REVITALIST LIFESTYLE AND WELLNESS | 0,015 | -100,00 % | Revitalist Lifestyle & Wellness Ltd: Revitalist Releases Benefits Program Giving Access To All for Ketamine Therapies Changing the Narrative of Mental Health to Risk Mitigation | Vancouver, British Columbia--(Newsfile Corp. - November 25, 2024) - Revitalist Lifestyle and Wellness Ltd. (CSE: CALM) (OTC: RVLWF) (FSE: 4DO) (the "Company") announces release of a benefits plan to... ► Artikel lesen |
Das Unternehmen SCIBASE HOLDING AB kann der Branche Gesundheitswesen zugeordnet werden. Die relative Kursveränderung beträgt aktuell -12,12 % bei einem Aktienkurs von 0,017 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu SCIBASE HOLDING AB finden Sie auf Wallstreet Online.
